Revisión del género Pseudognaphalium (Asteraceae, Gnaphalieae) en Chile

The genus Pseudognaphalium is one of the largest genera of the tribe Gnaphalieae (Asteraceae) with about 90 species with worldwide distribution. The vast majority of species are found in South, Central and North America, but some species also occur in Asia and Africa. This work includes the revision of 12 species of Pseudognaphalium from Chile, P. aldunateoides, P. cabrerae, P. cheiranthifolium, P. cymatoides, P. gayanum, P. lacteum, P. landbeckii, P. munoziae, P. psilophyllum, P. remyanum, P. tarapacanum, and P. viravira. A key is provided for their identification, as well as morphological description, illustration, geographic distribution and habitat, distribution maps, phenology, additional material examined, distinguishing characters and taxonomic affinities for each taxon. The new combination Pseudognaphalium cabrerae (S.E. Freire) S.E. Freire, N. Bayón, C. Baeza, Giuliano & C. Monti, is proposed. The following taxa are newly synonymized: Gnaphalium diminutivum, Pseudognaphalium perpusillum, with P. aldunateoides; G. canum, G. ulophyllum, P. moelleri with P. cymatoides; P. heterophyllum, P. heterotrichum, G. pseudohelichrysum, P. robustum with P. gayanum; P. glandulosum with P. psilophyllum; G. longifolium, G. subnudum, P. andicola, P. coquimbense, P. illapelinum, P. montevidense, P. pratense, with P. viravira. Lectotypes are newly designated for Gnaphalium acutifolium, G. araucanum, G. argyrolepis, G. canum, G. cymatoides, G. glandulosum, G. heterophyllum, G. illapelinum, G. lacteum, G. landbeckii, G. moelleri, G. ramosum, G. remyanum, G. subnudum, G. tarapacanum, G. ulophyllum, and G. viravira. A neotype is designated for G. psilophyllum.El género Pseudognaphalium, con cerca de 90 especies de distribución cosmopolita, es uno de los géneros de la tribu Gnaphalieae con mayor número de especies, principalmente distribuidas en América del Sur, Central y del Norte, aunque algunas también están presentes en Asia y África. Este trabajo comprende la revisión de 12 especies de Pseudognaphalium para Chile, P. aldunateoides, P. cabrerae, P. cheiranthifolium, P. cymatoides, P. gayanum, P. lacteum, P. landbeckii, P. munoziae, P. psilophyllum, P. remyanum, P. tarapacanum y P. viravira. Se incluye una clave para identificarlas y para cada una de las especies se brinda descripción, ilustración, fenología, distribución geográfica y hábitat, mapa de distribución, material adicional examinado y afinidades taxonómicas. Sobre la base del estudio de los materiales tipo, se establecen los siguientes nuevos sinónimos: Gnaphalium diminutivum, Pseudognaphalium perpusillum, con P. aldunateoides; G. canum, G. ulophyllum, P. moelleri con P. cymatoides; P. heterophyllum, P. heterotrichum, G. pseudohelichrysum, P. robustum, con P. gayanum; P. glandulosum con P. psilophyllum; G. longifolium, G. subnudum, P. andicola, P. coquimbense, P. illapelinum, P. montevidense, P. pratense, con P. viravira; se designan lectotipos para las siguientes especies: Gnaphalium acutifolium, G. araucanum, G. argyrolepis, G. canum, G. cymatoides, G. glandulosum, G. heterophyllum, G. illapelinum, G. lacteum, G. landbeckii, G. moelleri, G. ramosum, G. remyanum, G. subnudum, G. tarapacanum, G. ulophyllum, G. viravira y se designa el neotipo para G. psilophyllum.Facultad de Ciencias Agrarias y Forestale

Revisión del género Pseudognaphalium (Asteraceae, Gnaphalieae) en Chile

The genus Pseudognaphalium is one of the largest genera of the tribe Gnaphalieae (Asteraceae) with about 90 species with worldwide distribution. The vast majority of species are found in South, Central and North America, but some species also occur in Asia and Africa. This work includes the revision of 12 species of Pseudognaphalium from Chile, P. aldunateoides, P. cabrerae, P. cheiranthifolium, P. cymatoides, P. gayanum, P. lacteum, P. landbeckii, P. munoziae, P. psilophyllum, P. remyanum, P. tarapacanum, and P. viravira. A key is provided for their identification, as well as morphological description, illustration, geographic distribution and habitat, distribution maps, phenology, additional material examined, distinguishing characters and taxonomic affinities for each taxon. The new combination Pseudognaphalium cabrerae (S.E. Freire) S.E. Freire, N. Bayón, C. Baeza, Giuliano & C. Monti, is proposed. The following taxa are newly synonymized: Gnaphalium diminutivum, Pseudognaphalium perpusillum, with P. aldunateoides; G. canum, G. ulophyllum, P. moelleri with P. cymatoides; P. heterophyllum, P. heterotrichum, G. pseudohelichrysum, P. robustum with P. gayanum; P. glandulosum with P. psilophyllum; G. longifolium, G. subnudum, P. andicola, P. coquimbense, P. illapelinum, P. montevidense, P. pratense, with P. viravira. Lectotypes are newly designated for Gnaphalium acutifolium, G. araucanum, G. argyrolepis, G. canum, G. cymatoides, G. glandulosum, G. heterophyllum, G. illapelinum, G. lacteum, G. landbeckii, G. moelleri, G. ramosum, G. remyanum, G. subnudum, G. tarapacanum, G. ulophyllum, and G. viravira. A neotype is designated for G. psilophyllum.El género Pseudognaphalium, con cerca de 90 especies de distribución cosmopolita, es uno de los géneros de la tribu Gnaphalieae con mayor número de especies, principalmente distribuidas en América del Sur, Central y del Norte, aunque algunas también están presentes en Asia y África. Este trabajo comprende la revisión de 12 especies de Pseudognaphalium para Chile, P. aldunateoides, P. cabrerae, P. cheiranthifolium, P. cymatoides, P. gayanum, P. lacteum, P. landbeckii, P. munoziae, P. psilophyllum, P. remyanum, P. tarapacanum y P. viravira. Se incluye una clave para identificarlas y para cada una de las especies se brinda descripción, ilustración, fenología, distribución geográfica y hábitat, mapa de distribución, material adicional examinado y afinidades taxonómicas. Sobre la base del estudio de los materiales tipo, se establecen los siguientes nuevos sinónimos: Gnaphalium diminutivum, Pseudognaphalium perpusillum, con P. aldunateoides; G. canum, G. ulophyllum, P. moelleri con P. cymatoides; P. heterophyllum, P. heterotrichum, G. pseudohelichrysum, P. robustum, con P. gayanum; P. glandulosum con P. psilophyllum; G. longifolium, G. subnudum, P. andicola, P. coquimbense, P. illapelinum, P. montevidense, P. pratense, con P. viravira; se designan lectotipos para las siguientes especies: Gnaphalium acutifolium, G. araucanum, G. argyrolepis, G. canum, G. cymatoides, G. glandulosum, G. heterophyllum, G. illapelinum, G. lacteum, G. landbeckii, G. moelleri, G. ramosum, G. remyanum, G. subnudum, G. tarapacanum, G. ulophyllum, G. viravira y se designa el neotipo para G. psilophyllum.Facultad de Ciencias Agrarias y Forestale

Revisión del género Pseudognaphalium (Asteraceae, Gnaphalieae) en Chile

The genus Pseudognaphalium is one of the largest genera of the tribe Gnaphalieae (Asteraceae) with about 90 species with worldwide distribution. The vast majority of species are found in South, Central and North America, but some species also occur in Asia and Africa. This work includes the revision of 12 species of Pseudognaphalium from Chile, P. aldunateoides, P. cabrerae, P. cheiranthifolium, P. cymatoides, P. gayanum, P. lacteum, P. landbeckii, P. munoziae, P. psilophyllum, P. remyanum, P. tarapacanum, and P. viravira. A key is provided for their identification, as well as morphological description, illustration, geographic distribution and habitat, distribution maps, phenology, additional material examined, distinguishing characters and taxonomic affinities for each taxon. The new combination Pseudognaphalium cabrerae (S.E. Freire) S.E. Freire, N. Bayón, C. Baeza, Giuliano & C. Monti, is proposed. The following taxa are newly synonymized: Gnaphalium diminutivum, Pseudognaphalium perpusillum, with P. aldunateoides; G. canum, G. ulophyllum, P. moelleri with P. cymatoides; P. heterophyllum, P. heterotrichum, G. pseudohelichrysum, P. robustum with P. gayanum; P. glandulosum with P. psilophyllum; G. longifolium, G. subnudum, P. andicola, P. coquimbense, P. illapelinum, P. montevidense, P. pratense, with P. viravira. Lectotypes are newly designated for Gnaphalium acutifolium, G. araucanum, G. argyrolepis, G. canum, G. cymatoides, G. glandulosum, G. heterophyllum, G. illapelinum, G. lacteum, G. landbeckii, G. moelleri, G. ramosum, G. remyanum, G. subnudum, G. tarapacanum, G. ulophyllum, and G. viravira. A neotype is designated for G. psilophyllum.El género Pseudognaphalium, con cerca de 90 especies de distribución cosmopolita, es uno de los géneros de la tribu Gnaphalieae con mayor número de especies, principalmente distribuidas en América del Sur, Central y del Norte, aunque algunas también están presentes en Asia y África. Este trabajo comprende la revisión de 12 especies de Pseudognaphalium para Chile, P. aldunateoides, P. cabrerae, P. cheiranthifolium, P. cymatoides, P. gayanum, P. lacteum, P. landbeckii, P. munoziae, P. psilophyllum, P. remyanum, P. tarapacanum y P. viravira. Se incluye una clave para identificarlas y para cada una de las especies se brinda descripción, ilustración, fenología, distribución geográfica y hábitat, mapa de distribución, material adicional examinado y afinidades taxonómicas. Sobre la base del estudio de los materiales tipo, se establecen los siguientes nuevos sinónimos: Gnaphalium diminutivum, Pseudognaphalium perpusillum, con P. aldunateoides; G. canum, G. ulophyllum, P. moelleri con P. cymatoides; P. heterophyllum, P. heterotrichum, G. pseudohelichrysum, P. robustum, con P. gayanum; P. glandulosum con P. psilophyllum; G. longifolium, G. subnudum, P. andicola, P. coquimbense, P. illapelinum, P. montevidense, P. pratense, con P. viravira; se designan lectotipos para las siguientes especies: Gnaphalium acutifolium, G. araucanum, G. argyrolepis, G. canum, G. cymatoides, G. glandulosum, G. heterophyllum, G. illapelinum, G. lacteum, G. landbeckii, G. moelleri, G. ramosum, G. remyanum, G. subnudum, G. tarapacanum, G. ulophyllum, G. viravira y se designa el neotipo para G. psilophyllum

Non-Detection of Human Herpesvirus 8 (HHV-8) DNA in HHV-8-Seropositive Blood Donors from Three Brazilian Regions

Human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV), is the etiologic agent of all forms of Kaposi's sarcoma, primary effusion lymphoma and the plasmablastic cell variant of multicentric Castleman disease. In endemic areas of sub-Saharan Africa, blood transfusions have been associated with a substantial risk of HHV-8 transmission. By contrast, several studies among healthy blood donors from North America have failed to detect HHV-8 DNA in samples of seropositive individuals. In this study, using a real-time PCR assay, we investigated the presence of HHV-8 DNA in whole-blood samples of 803 HHV-8 blood donors from three Brazilian states (São Paulo, Amazon, Bahia) who tested positive for HHV-8 antibodies, in a previous multicenter study. HHV-8 DNA was not detected in any sample. Our findings do not support the introduction of routine HHV-8 screening among healthy blood donors in Brazil. (WC = 140)

Emotional, hyperactivity and inattention problems in adolescents with immunocompromising chronic diseases during the COVID-19 pandemic

Objective: To assess factors associated with emotional changes and Hyperactivity/Inattention (HI) motivated by COVID-19 quarantine in adolescents with immunocompromising diseases. Methods: A cross-sectional study included 343 adolescents with immunocompromising diseases and 108 healthy adolescents. Online questionnaires were answered including socio-demographic data and self-rated healthcare routine during COVID-19 quarantine and validated surveys: Strengths and Difficulties Questionnaire (SDQ), Pittsburgh Sleep Quality Index (PSQI), Pediatric Quality of Life Inventory 4.0 (PedsQL4.0). Results: The frequencies of abnormal emotional SDQ scores from adolescents with chronic diseases were similar to those of healthy subjects (110/343 [32%] vs. 38/108 [35%], p = 0.548), as well as abnormal hyperactivity/inattention SDQ scores (79/343 [23%] vs. 29/108 [27%], p = 0.417). Logistic regression analysis of independent variables associated with abnormal emotional scores from adolescents with chronic diseases showed: female sex (Odds Ratio [OR = 3.76]; 95% Confidence Interval (95% CI) 2.00‒7.05; p < 0.001), poor sleep quality (OR = 2.05; 95% CI 1.08‒3.88; p = 0.028) and intrafamilial violence during pandemic (OR = 2.17; 95% CI 1.12‒4.19; p = 0.021) as independently associated with abnormal emotional scores, whereas total PedsQL score was inversely associated with abnormal emotional scores (OR = 0.95; 95% CI 0.93‒0.96; p < 0.0001). Logistic regression analysis associated with abnormal HI scores from patients evidenced that total PedsQL score (OR = 0.97; 95% CI 0.95‒0.99; p = 0.010], changes in medical appointments during the pandemic (OR = 0.39; 95% CI 0.19-0.79; p = 0.021), and reliable COVID-19 information (OR = 0.35; 95% CI 0.16‒0.77; p = 0.026) remained inversely associated with abnormal HI scores. Conclusion: The present study showed emotional and HI disturbances in adolescents with chronic immunosuppressive diseases during the COVID-19 pandemic. It reinforces the need to promptly implement a longitudinal program to protect the mental health of adolescents with and without chronic illnesses during future pandemics

Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis

Objective To assess organ damage, with emphasis on the cardiovascular system, over the different stages of the disease in a large SLE cohort.Methods Multicentre, longitudinal study of a cohort of 4219 patients with SLE enrolled in the Spanish Society of Rheumatology Lupus Registry. Organ damage was ascertained using the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). We longitudinally analysed SDI (globally and for each domain) over time only in the 1274 patients whose dates of damage events had been recorded.Results During the first year after diagnosis of SLE, 20% of the 1274 patients presented with new damage manifestations. At years 2 and 3, new damage was recorded in 11% and 9% of patients. The annual percentage of patients with new damage after year 5 decreased to 5%. In the first year with the disease, most damage was accumulated in the musculoskeletal, neuropsychiatric and renal systems; in later stages, most damage was in the musculoskeletal, ocular and cardiovascular systems. Considering 'cerebrovascular accident' and 'claudication for 6 months' as cardiovascular items, the cardiovascular system was the second most affected system during the early stages of SLE, with 19% of the patients who presented with damage affected at first year after diagnosis. During the late stages, 20-25% of the patients presenting with new damage did so in this modified cardiovascular domain of the SDI.Conclusions New damage occurs mainly during the first year following diagnosis of SLE. Cardiovascular damage is relevant in both the early and the late stages of the disease. Strategies to prevent cardiovascular damage should be implemented early after diagnosis of SLE

Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases

Background: In Brazil, we are facing an alarming epidemic scenario of Yellow fever (YF), which is reaching the most populous areas of the country in unvaccinated people. Vaccination is the only effective tool to prevent YF. In special situations, such as patients with chronic immune-mediated inflammatory diseases (CIMID), undergoing immunosuppressive therapy, as a higher risk of severe adverse events may occur, assessment of the risk-benefit ratio of the yellow fever vaccine (YFV) should be performed on an individual level. Main body of the abstract: Faced with the scarcity of specific orientation on YFV for this special group of patients, the Brazilian Rheumatology Society (BRS) endorsed a project aiming the development of individualized YFV recommendations for patients with CIMID, guided by questions addressed by both medical professionals and patients, followed an internationally validated methodology (GIN-McMaster Guideline Development). Firstly, a systematic review was carried out and an expert panel formed to take part of the decision process, comprising BRS clinical practitioners, as well as individuals from the Brazilian Dermatology Society (BDS), Brazilian Inflammatory Bowel Diseases Study Group (GEDIIB), and specialists on infectious diseases and vaccination (from Tropical Medicine, Infectious Diseases and Immunizations National Societies); in addition, two representatives of patient groups were included as members of the panel. When the quality of the evidence was low or there was a lack of evidence to determine the recommendations, the decisions were based on the expert opinion panel and a Delphi approach was performed. A recommendation was accepted upon achieving ≥80% agreement among the panel, including the patient representatives. As a result, eight recommendations were developed regarding the safety of YFV in patients with CIMID, considering the immunosuppression degree conferred by the treatment used. It was not possible to establish recommendations on the effectiveness of YFV in these patients as there is no consistent evidence to support these recommendations. Conclusion: This paper approaches a real need, assessed by clinicians and patient care groups, to address specific questions on the management of YFV in patients with CIMID living or traveling to YF endemic areas, involving specialists from many areas together with patients, and might have global applicability, contributing to and supporting vaccination practices. We recommended a shared decision-making approach on taking or not the YFV